In 2024, with the rapid development of the global pharmaceutical industry and increasingly stringent regulatory requirements, ensuring the quality and safety of drug production has become a core issue that pharmaceutical companies cannot afford to overlook. Cells, as biopharmaceuticals with signific
The serum - free medium for stem cells of Yocon Biotech has been approved for 510K Class II medical device registration by the US FDA, with the registration certificate number K232543. It is the second global and the first Chinese registration certificate of this product issued by the US FDA. The se
Recently, Yocon's GMP - grade Cell Cryopreservation Solution (NC1010) and Stem Cell Mild Digestive Enzyme (NC1004) have been successfully linked and activated in the US FDA. This not only means that these two products can support Chinese pharmaceutical companies in applying for the approval of cell
